Statin use and the risk of surgical site infections in elderly patients undergoing elective surgery

Archives of Surgery

Volumn 144, Issue 10, 2009, Pages 938-945

  Daneman, Nick ^a   Thiruchelvam, Deva ^a   Redelmeier, Donald A ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

AGED; ARTICLE; COMORBIDITY; CONSULTATION; CONTROLLED STUDY; DRUG USE; ELECTIVE SURGERY; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL READMISSION; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPERATION DURATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; RISK REDUCTION; SURGICAL INFECTION; SURGICAL MORTALITY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; ONTARIO; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; SURGICAL WOUND INFECTION;

EID: 70350247617     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2009.167     Document Type: Article

References (59)

1. Coskun D, Aytac J, Aydinli A, Bayer A. Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey. J Hosp Infect. 2005;60(2):176-179. (Pubitemid 40590588)
2. Coello R, Charlett A, Wilson J, Ward V, Pearson A, Borriello P. Adverse impact of surgical site infections in English hospitals. J Hosp Infect. 2005;60(2):93-103. (Pubitemid 40590575)
3. Monge Jodra V, Sainz de Los Terreros Soler L, Diaz-Agero Perez C, Saa Requejo CM, Plana Farras N. Excess length of stay attributable to surgical site infection following hip replacement: a nested case-control study. Infect Control Hosp Epidemiol. 2006;27(12):1299-1303. (Pubitemid 46052275)
4. Hollenbeak CS, Murphy D, Dunagan WC, Fraser VJ. Nonrandom selection and the attributable cost of surgical-site infections. Infect Control Hosp Epidemiol. 2002;23(4):177-182. (Pubitemid 34297270)
5. Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell DA Jr. Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg. 2004; 199(4):531-537.
6. Urban JA. Cost analysis of surgical site infections. Surg Infect (Larchmt). 2006; 7(suppl 1):S19-S22.
7. Graves N, Halton K, Lairson D. Economics and preventing hospital-acquired infection: broadening the perspective. Infect Control Hosp Epidemiol. 2007;28 (2):178-184. (Pubitemid 46374158)
8. Hollenbeak CS, Murphy DM, Koenig S, Woodward RS, Dunagan WC, Fraser VJ. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest. 2000;118(2):397-402. (Pubitemid 30637806)
9. Nespoli A, Gianotti L, Totis M, et al. Correlation between postoperative infections and long-term survival after colorectal resection for cancer. Tumori. 2004; 90(5):485-490. (Pubitemid 39556798)
10. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep. 2007; 122(2):160-166.
11. Weinstein RA, Siegel JD, Brennan PJ. Infection-control report cards: securing patient safety. N Engl J Med. 2005;353(3):225-227. (Pubitemid 41058321)
12. Krizek TJ, Robson MC. Evolution of quantitative bacteriology in wound management. Am J Surg. 1975;130(5):579-584.
13. Hackam DJ, Ford HR. Cellular, biochemical, and clinical aspects of wound healing. Surg Infect (Larchmt). 2002;3(suppl 1):S23-S35.
14. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR; Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Guideline for Prevention of Surgical Site Infection, 1999.Am J Infect Control. 1999;27(2):97-132, quiz 133-134, discussion 96.
15. Hedrick TL, Heckman JA, Smith RL, Sawyer RG, Friel CM, Foley EF. Efficacy of protocol implementation on incidence of wound infection in colorectal operations. J Am Coll Surg. 2007;205(3):432-438.
16. Almuti K, Rimawi R, Spevack D, Ostfeld RJ. Effects of statins beyond lipid lowering: potential for clinical benefits. Int J Cardiol. 2006;109(1):7-15.
17. Mach F. Statins as immunomodulatory agents. Circulation. 2004;109(21)(suppl 1):II15-II17.
18. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis. 2007;7(5):358-368. (Pubitemid 46590065)
19. Jerwood S, Cohen J. Unexpected antimicrobial effect of statins. J Antimicrob Chemother. 2008;61(2):362-364.
20. Wiggin H, Salama H, Palcu CT, Sobel JD, Akins RA. Surprising selective in vitro antibacterial activities of statins. Paper presented at: International Conference of Antimicrobial Agents and Chemotherapeutics; September 20, 2007; Chicago, IL.
21. Merx MW, Liehn EA, Janssens U, et al. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation. 2004; 109(21):2560-2565. (Pubitemid 38720557)
22. Merx MW, Liehn EA, Graf J, et al. Statin treatment after onset of sepsis in a murine model improves survival. Circulation. 2005;112(1):117-124. (Pubitemid 40962577)
23. Pruefer D, Makowski J, Schnell M, et al. Simvastatin inhibits inflammatory properties of Staphylococcus aureus α-toxin. Circulation. 2002;106(16):2104-2110. (Pubitemid 35192817)
24. Liappis AP, Kan VL, Rochester CG, Simon GL. The effect of statins on mortality in patients with bacteremia. Clin Infect Dis. 2001;33(8):1352-1357.
25. Almog Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation. 2004;110(7):880-885. (Pubitemid 39096018)
26. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respir Res. 2005;6:82. (Pubitemid 41410154)
27. Hackam DG, Mamdani M, Li P, Redelmeier DA. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet. 2006; 367(9508):413-418. (Pubitemid 43184262)
28. Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med. 2006; 32(1):75-79. (Pubitemid 43039379)
29. Thomsen RW, Hundborg HH, Johnsen SP, et al. Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med. 2006; 34(4):1080-1086.
30. Almog Y, Novack V, Eisinger M, Porath A, Novack L, Gilutz H. The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases. Crit Care Med. 2007;35(2):372-378. (Pubitemid 46148524)
31. Gupta R, Plantinga LC, Fink NE, et al. Statin use and sepsis events [corrected] in patients with chronic kidney disease [published correction appears in JAMA. 2008;299(7):765]. JAMA. 2007;297(13):1455-1464. (Pubitemid 351281583)
32. Mortensen EM, Restrepo MI, Copeland LA, Pugh MJ, Anzueto A. Statins and outcomes in patients with pneumonia: not only healthy user bias. BMJ. 2006; 333(7578):1123-1124.
33. Coleman CI, Lucek DM, Hammond J, White CM. Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin. 2007;23 (8):1783-1790. (Pubitemid 47300376)
34. Imtiaz SA, Buth KJ. Impact of preoperative statin use on sepsis and deep sternal wound infection following cardiac surgery [abstract P50]. Circulation. 2005;111 (20):e320.
35. Hauer-Jensen M, Fort C, Mehta JL, Fink LM. Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy. Hernia. 2006; 10(1):48-52.
36. Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10(2):67-71. (Pubitemid 37028596)
37. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13(10):606-608.
38. Delgado-Rodríguez M, Gomez-Ortega A, Sillero-Arenas M, Llorca J. Epidemiology of surgical-site infections diagnosed after hospital discharge: a prospective cohort study. Infect Control Hosp Epidemiol. 2001;22(1):24-30. (Pubitemid 32065150)
39. Sands K, Vineyard G, Platt R. Surgical site infections occurring after hospital discharge. J Infect Dis. 1996;173(4):963-970. (Pubitemid 26001174)
40. Sands KE, Yokoe DS, Hooper DC, et al. Detection of postoperative surgical-site infections: comparison of health plan-based surveillance with hospital-based programs. Infect Control Hosp Epidemiol. 2003;24(10):741-743.
41. Hirschhorn LR, Currier JS, Platt R. Electronic surveillance of antibiotic exposure and coded discharge diagnoses as indicators of postoperative infection and other quality assurance measures. Infect Control Hosp Epidemiol. 1993;14(1):21-28.
42. Kennon J, Russo P. A comparison of two methods for identifying surgical site infections following orthopaedic surgery. J Hosp Infect. 2001;49(4):302-304. (Pubitemid 34083092)
43. Ontario Ministry of Health and Long-Term Care; Health Results Team for Information Management; Canadian Health Information Management Association; Canadian Institute for Health Information. Reabstraction study of the Ontario case costing facilities for fiscal years 2002/2003 and 2003/2004. Ontario Ministry of Health and Long-Term Care Web site. November 2005. http://hdl/handle.net/1873/1467. Accessed August 2008.
44. Redelmeier DA, Thiruchelvam D, Daneman N. Introducing a methodology for estimating duration of surgery in health services research. J Clin Epidemiol. 2008; 61(9):882-889.
45. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
46. Cummings P, McKnight B, Greenland S. Matched cohort methods for injury research. Epidemiol Rev. 2003;25:43-50. (Pubitemid 36944550)
47. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121-130.
48. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 Pt 2):757-763.
49. Biscione FM, Couto RC, Pedrosa TM, Neto MC. Comparison of the risk of surgical site infection after laparoscopic cholecystectomy and open cholecystectomy. Infect Control Hosp Epidemiol. 2007;28(9):1103-1106. (Pubitemid 47345275)
50. Ammori BJ, Larvin M, McMahon MJ. Elective laparoscopic cholecystectomy: preoperative prediction of duration of surgery. Surg Endosc. 2001;15(3):297-300. (Pubitemid 32294707)
51. Ikhena SE, Oni M, Naftalin NJ, Konje JC. The effect of the learning curve on the duration and peri-operative complications of laparoscopically assisted vaginal hysterectomy. Acta Obstet Gynecol Scand. 1999;78(7):632-635. (Pubitemid 29322475)
52. Traverso LW, Koo KP, Hargrave K, et al. Standardizing laparoscopic procedure time and determining the effect of patient age/gender and presence or absence of surgical residents during operation: a prospective multicenter trial. Surg Endosc. 1997; 11(3):226-229. (Pubitemid 127523131)
53. Scott JD, Forrest A, Feuerstein S, Fitzpatrick P, Schentag JJ. Factors associated with postoperative infection. Infect Control Hosp Epidemiol. 2001;22(6):347-351.
54. Rantala A, Lehtonen OP, Niinikoski J. Alcohol abuse: a risk factor for surgical wound infections? Am J Infect Control. 1997;25(5):381-386. (Pubitemid 27446848)
55. Oliveira AC, Carvalho DV. Postdischarge surveillance: the impact on surgical site infection incidence in a Brazilian university hospital. Am J Infect Control. 2004; 32(6):358-361.
56. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32(8):470-485.
57. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ. 2006;333(7576):999.
58. Schouten O, Kertai MD, Bax JJ, et al. Safety of perioperative statin use in highrisk patients undergoing major vascular surgery. Am J Cardiol. 2005;95(5): 658-660. (Pubitemid 40255263)
59. Yokoe DS, Noskin GA, Cunnigham SM, et al. Enhanced identification of postoperative infections among inpatients. Emerg Infect Dis. 2004;10(11):1924-1930. (Pubitemid 39458556)